HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US States Take Aim At Microplastics Among ‘Overwhelming’ Number Of Bills With Cosmetics Relevance

Executive Summary

Plastic concerns loom large in a growing patchwork of legislative proposals at the US state level with implications for cosmetics businesses.

You may also be interested in...

The Replacements: Cosmetic Ingredient Suppliers At Ready With Microplastic Alternatives As EU Ban Unfolds

HBW Insight reached out to suppliers of microplastic alternatives for cosmetics use to discuss their offerings and preparedness for demand surges under phased REACH prohibitions.

California DTSC Plans To Add Microplastics To Candidate Chemicals List

California’s Department of Toxic Substances Control proposes adding microplastics to its list of Candidate Chemicals, which would not have a regulatory impact at first but could lead to Priority Product selections, alternatives analyses, and regulatory responses to reduce or eliminate adverse impacts to public health and the environment. Microplastic-containing cosmetics are among products in the DTSC's line of sight.

Group Of European Firms Say EC’s Proposed Ban On Microplastics In Cosmetics Not ‘Far Or Fast Enough’

Firms removing microplastics from cosmetic products maintain European Commission’s deadline for removal across the sector is too generous. Weleda contends nine of 10 personal care products contain microplastics and 7 kg plastics a minute flushed into environment from cosmetics.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts